OPBP-1
OPBP-1 is a D-peptide obtained by phage display screening, molecular docking and molecular dynamics simulation. OPBP-1 has high stability and strong antitumor and oral activity. OPBP-1 can selectively bind PD-L1 protein, significantly block the interaction between PD-1 and PD-L1, and this blocking effect helps to restore and improve the function of T lymphocytes and reduce the proportion of bone marrow derived suppressor cells (MDSCs) to combat tumor-induced immune escape. OPBP-1 can be used in cancer immunotherapy research[1].
Product Specifications
UNSPSC
12352209
Target
PD-1/PD-L1
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/opbp-1.html
Purity
99.88
Solubility
H2O : 5 mg/mL (ultrasonic)
Smiles
Molecular Formula
C64H92N20O19S
Molecular Weight
1477.60
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
AKT1S1 Recombinant Antibody, AbBy Fluor™ 594 Conjugated
Angiopoietin Like Protein 4 (ANGPTL4) BioAssayTM ELISA Kit (Rat) discontinued
Angiopoietin Like Protein 4 (ANGPTL4) BioAssayTM ELISA Kit (Rat) discontinued
ITGA7 CRISPR All-in-one AAV vector set (with saCas9)(Human)
